ID   hTERT-HME1
AC   CVCL_3383
SY   hTERT-HME-1; hTERTHME1; HME-1; HME1; ME16C
DR   CLO; CLO_0004291
DR   CLO; CLO_0037172
DR   EFO; EFO_0022410
DR   ATCC; CRL-4010
DR   BioSample; SAMN03471718
DR   BioSample; SAMN05292449
DR   ENCODE; ENCBS062ZDL
DR   ENCODE; ENCBS245QRF
DR   Evercyte; CHT-044-0236
DR   GEO; GSM756369
DR   GEO; GSM1008912
DR   GEO; GSM7701480
DR   GEO; GSM7701481
DR   LINCS_HMS; 50056
DR   LINCS_LDP; LCL-2083
DR   Wikidata; Q54896623
RX   PubMed=19582160;
RX   PubMed=24162158;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544520
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: 48-64 hours (Evercyte=CHT-044-0236); ~25 hours (PBCF).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): ATCC=CRL-4010
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,20
ST   D19S433: 14,16.2
ST   D21S11: 28,31
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 7,12
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 12
ST   TH01: 7,8
ST   TPOX: 10,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
RX   PubMed=19582160; DOI=10.1371/journal.pone.0006146; PMCID=PMC2702084;
RA   Kao J., Salari K., Bocanegra M., Choi Y.-L., Girard L., Gandhi J.,
RA   Kwei K.A., Hernandez-Boussard T., Wang P., Gazdar A.F., Minna J.D.,
RA   Pollack J.R.;
RT   "Molecular profiling of breast cancer cell lines defines relevant
RT   tumor models and provides a resource for cancer gene discovery.";
RL   PLoS ONE 4:e6146.1-e6146.16(2009).
//
RX   PubMed=24162158; DOI=10.1007/s10549-013-2743-3; PMCID=PMC3832776;
RA   Prat A., Karginova O., Parker J.S., Fan C., He X.-P., Bixby L.M.,
RA   Harrell J.C., Roman E., Adamo B., Troester M.A., Perou C.M.;
RT   "Characterization of cell lines derived from breast cancers and normal
RT   mammary tissues for the study of the intrinsic molecular subtypes.";
RL   Breast Cancer Res. Treat. 142:237-255(2013).
//